Abstract
In this study, our aim was to evaluate the role of lymphovascular invasion (LVI) in the prognosis of patients with early stage breast cancer. The medical records of more than 7000 patients who suffered from invasive breast cancer and had undergone surgical treatment since December 1994 till December 2019, retrospectively. Patient’s history, physical examination and the clinicopathological features, histopathology characteristics, immunohistochemical findings, adjuvant systemic therapy, recurrence rate, metastasis-free survival (MFS), disease-free survival (DFS), and overall survival (OS) were reviewed. A total of 5425 eligible patients were categorized into two groups based on the presence of LVI; 3031 (55.9%) patients had no LVI (group 1) and LVI was present in 2394 (44.1%) patients (group 2), then divided into LN-positive and -negative groups. Presence of LVI was significantly associated with patient age ≤ 40 years (p = 0.048), high histological grade (grades II and III, p < 0.001), tumor size between 2–5 cm and > 5 cm (p < 0.001), number of involved LN ≥ 4 (p < 0.001), and negative ER (p = 0.042) tumors. Five-year OS, MFS, and DFS were 93%, 88.9%, and 76.1% and 85.2%, 84.7%, and 73.6 in groups 1 and 2, respectively (P < 0.001). On multivariate analysis, LVI was an independent prognostic factor for DFS in all patients. Furthermore, histological grade II, histological grade III, and a higher number of involved LNs (≥ 4) were independent predictors in all patients. Thus, the presence of LVI can be considered as an independent prognostic factor for patients with operable breast cancer, irrespective of the LN status.
Similar content being viewed by others
Data Availability
All data and materials as well as software application or custom code support the published claims and comply with field standards.
Code Availability
SPSS software ® for windows®, version 21.0
References
Ferlay J, Parkin D, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765–781
Harris JR, Lippman ME, Osborne CK, Morrow M (2012) Diseases of the breast. Lippincott Williams & Wilkins
Woo CS, Silberman H, Nakamura SK, Ye W, Sposto R, Colburn W et al (2002) Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. Am J Surg 184(4):337–340
Davis BW, Gelber R, Goldhirsch A, Hartmann WH, Hollaway L, Russell I et al (1985) Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Hum Pathol 16(12):1212–1218
Song YJ, Shin SH, Cho JS, Park MH, Yoon JH, Jegal YJ (2011) The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer. J Breast Cancer 14(3):198–203
Lee A, Pinder S, Macmillan R, Mitchell M, Ellis I, Elston C et al (2006) Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 42(3):357–362
Ejlertsen B, Jensen M-B, Rank F, Rasmussen BB, Christiansen P, Kroman N et al (2009) Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst 101(10):729–35
Rakha EA, Martin S, Lee AH, Morgan D, Pharoah PD, Hodi Z et al (2012) The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer 118(15):3670–3680
Zhang S, Zhang D, Gong M, Wen L, Liao C, Zou L (2017) High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer. BMC Cancer 17(1):335
De Mascarel I, Bonichon F, Durand M, Mauriac L, MacGrogan G, Soubeyran I et al (1998) Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers. European journal of cancer 34(1):58–65
Bettelheim R, Penman H, Thornton-Jones H, Neville A (1984) Prognostic significance of peritumoral vascular invasion in breast cancer. Br J Cancer 50(6):771–777
Lauria R, Perrone F, Carlomagno C, De Laurentiis M, Morabito A, Gallo C et al (1995) The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 76(10):1772–1778
Weigand RA, Isenberg WM, Russo J, Brennan MJ, Rich MA (1982) Blood vessel invasion and axillary lymph node involvement as prognostic indicators for human breast cancer. Cancer 50(5):962–969
Colleoni M, Rotmensz N, Maisonneuve P, Sonzogni A, Pruneri G, Casadio C et al (2007) Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol 18(10):1632–1640
Locker A, Ellis I, Morgan D, Elston C, Mitchell A, Blamey R (1989) Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 76(9):890–894
O’Rourke S, Galea M, Morgan D, Euhus D, Pinder S, Ellis I et al (1994) Local recurrence after simple mastectomy. Br J Surg 81(3):386–389
Sundquist M, Thorstenson S, Klintenberg C, Brudin L, Nordenskjöld B (2000) Indicators of loco-regional recurrence in breast cancer. Eur J Surg Oncol (EJSO) 26(4):357–362
Clemente CG, Boracchi P, Andreola S, Vecchio MD, Veronesi P, Rilke FO (1992) Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer 69(6):1396–1403
Veronesi U, Marubini E, Vecchio MD, Manzari A, Andreola S, Greco M et al (1995) Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87(1):19–27
Goldhirsch A, Ingle JN, Gelber R, Coates A, Thürlimann B, Senn H-J et al (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 20(8):1319–1329
de Wolf C, Perry N (1996) European guidelines for quality assurance in mammography screening. Office for Official Publications of the European Communities, Luxembourg
Pinder S, Ellis I, Galea M, O’rouke S, Blamey R, Elston C (1994) Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 24(1):41–7
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the Ethics Committee of Shiraz University of Medical Sciences, Who determined that our study did not need ethical approval.
Consent to Participate
Informed consent was obtained from all individual participants included in the study.
Consent for Publication
Informed consent was obtained from all individual participants included in the study.
Conflicts of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Akrami, M., Meshksar, A., Ghoddusi, J.M. et al. Prognostic Role of Lymphovascular Invasion in Patients with Early Breast Cancer. Indian J Surg Oncol 12, 671–677 (2021). https://doi.org/10.1007/s13193-021-01367-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-021-01367-9